top of page
Danielle Rice 2022.jpg

Name: Danielle Rice


Position: Assistant Professor - McMaster University, Psychologist at St. Joseph’s Healthcare Hamilton (Ph.D., C. Psych, Supervised Practice), Collaborator with SPIN


Dr. Rice received her Ph.D. in clinical psychology from McGill University in 2022, under the supervision of Dr. Thombs. She continues to be involved in the Scleroderma Patient-centered Intervention Network (SPIN), DEPRESsion Screening Data (DEPRESSD), and the Meta-Research & Policy projects. Her research includes trying to develop and test interventions to support patients with mental health and addictions concerns, including those with chronic health conditions such as those with Scleroderma and their loved ones. 


Dr. Rice is currently an Assistant Professor at McMaster University in the Department of Psychiatry & Behavioural Neurosciences. She is also a psychologist (supervised practice) at St. Joseph’s Healthcare Hamilton in the Mood Disorders Program, where she provides individual and group therapy, conducts comprehensive psychological assessments, and she is actively involved in program evaluation, health system changes, and research related to depression and bipolar. Her role involves an important focus on equity, diversity, and inclusion for both research and clinical care.


Since 2014, Dr. Rice has published over 100 peer-reviewed articles in the respected leading journals (e.g., BMJ, Perspectives in Psychological Science, JAMA Intern Med). She is a co-investigator on numerous grants from the Canadian Institutes of Health Research (CIHR). She is interested in health policy and health systems research, evidence synthesis, and the reproducibility and methodological quality of studies, especially within the field of mental health.


Dr. Rice’s Publications:

Select Awards:

- Health System Impact Fellowship ($50, 000). Canadian Institutes of Health Research (CIHR), 2018-2019
- Outstanding Student in Rheumatology Award ($650). Association of Rheumatology Health Professionals, 2018
- Graduate Mobility Award ($4000). McGill University, 2018
- Vanier Canada Graduate Scholarship ($150, 000). Canadian Institutes of Health Research (CIHR), ($150, 000), 2017-2020
- Canadian Institutes of Health Research (CIHR) Doctoral Award ($105, 000, awarded but declined), 2017-2020
- Fonds de Recherche en Santé du Québec –Doctoral Award ($63, 000, awarded but declined), 2017-2020


Recent Publications:
Poulin, P., Bell, L., Rice, D.B., Shergill, Y., Fitzgerald, S., Cantave, R., Gauthier, R., et al., (2022). A Formal Evaluation of The Ottawa Hospital Pain Clinic Orientation Session: A Quality Improvement Project. Accepted to Canadian Journal of Pain.  


Wu, Y., Levis, B., Daray, F.M., […] & the DEPRESsion Screening Data (DEPRESSD) HADS Group. (2022). Comparison of the accuracy of the 7-item HADS Depression subscale and 14-item total HADS for screening for major depression: a systematic review and individual participant data meta-analysis. Accepted to Psychological Assessment.  


Shergill, Y., Rice, D.B., Khoo, E.L., Jarvis, V., Zhang, T., et al., (2022) Mindfulness Based Stress Reduction in Breast Cancer Survivors with Chronic Neuropathic Pain: A Randomized Controlled Trial. Pain Research and Management. 4020550. 1-14.  


Nassar, E., Levis, B., Neyer, M.A., Rice, D.B., Booij, L., Benedetti, A., & Thombs B.D. (2022). Transparency and completeness of reporting of depression screening tool accuracy studies: a meta-research review of adherence to the STARD statement. International Journal of Methods in Psychiatric Research. e1939. 1-10.


Dal Santo, T., Sun, Y., Wu, Y., He, C., Wang, Y., Jiang, X., Li, K., Bondari, O., Krishnan, A., Boruff, J.T., Rice, D.B., et al., (2022). Systematic Review of Mental Health Symptom Change by Sex or Gender in Early-COVID-19 Compared to PrePandemic. Accepted to Scientific Reports.


Syrowatka, A., Li, M., Gu, J., Yin, L., Rice, D.B., Gurevich, Y. (2022). Use of Linked Data to Assess the Impact of Including Out-of Hospital Deaths on Canadian National 30-Day In-Hospital Mortality Indicators: A Retrospective Cohort Study. Accepted to CMAJ Open.


Tasleem, A., Wang, Y., Li, K., Jiang, X., Krishnan, A., He, C., Sun, Y., Wu, Y., Fan, S., Boruff, J.T., Markham, S., Rice, D.B., et al., (2022). Effects of Mental Health Interventions among People Hospitalized with COVID-19 Infection: A Systematic Review of Randomized Controlled Trials. Accepted to General Hospital Psychiatry.  


Nassar, E.L., Levis, B., Neyer, N.A., Rice, D.B., Booij, L., Benedetti, A., & Thombs, B.D., (2022). Sample Size and Precision of Estimates in Studies of Depression Screening Tool Accuracy: A Meta-Research Review of Studies. Accepted to International Journal of Psychiatric Methods.


Bonardi, O., Wang, Y., Li, K., Jiang, X., Krishnan, A., He, C., Sun, Y., Wu, Y., Boruff, J.T., Markham, S., Rice, D.B., et al., (2022). Effects of COVID-19 Mental Health Interventions Among Children, Adolescents, and Adults Not Quarantined or Undergoing Treatment Due to COVID-19 Infection: A Systematic Review of Randomised Controlled Trials. Journal of Canadian Psychiatry. 1-15.  


Duval, A., Davis, C.G., Khoo, E.L., Romanow, H., Shergill, Y., Rice, D.B., Smith, A., Poulin, P., & Collins, B. (2022).  Mindfulness-Based Stress Reduction and Cognitive Function Among Breast Cancer Survivors: A Randomized Controlled Trial. Accepted to Cancer.


Nassar, E.L., Levis, B., Rice, D.B., Booij, L., Benedetti, A., & Thombs, B.D., (2022). Inclusion of Currently Diagnosed or Treated Individuals in Studies of Depression Screening Tool Accuracy: A Meta-Research Review of Studies Published in 20182021. Accepted to General Hospital Psychiatry.


Rice, D.B., Pham, B., Presseau, J., Tricco, A.C., & Moher, D. (2022). Characteristics of ‘Mega’ Peer Reviewers. 7, 1-7. Research Integrity and Peer Review.  Shergill, Y., Poulin, P., Rice, D.B., et al., & Smyth, C. (2022). An interdisciplinary Program for Familiar Faces with Chronic Pain Visiting the Emergency Department – Randomized Controlled Trial. Journal of the American College of Emergency Physicians Open. 3:e12628. 


Harel, D., Levis, B., Sun, Y., et al., & DEPRESSD HADS Group. (2021). External Validation of a Shortened Screening Tool Using Individual Participant Data MetaAnalysis: a Case Study of the Patient Health Questionnaire-Dep-4. Accepted to Methods.


Mc Cord, K.A., Imran, M., Rice, D.B., et al., (2021). Reporting or Randomized Trials Using Registries was Often Inadequate and Hindered the Interpretation of Results. Accepted to Journal of Clinical Epidemiology.  


Presentations (selected):

Select Oral Presentations:

Rice, D.B. (2022). Caring for a Loved One. Scleroderma Canada Conference. Niagara Falls, Ontario. September 17, 2022.  


Rice, D.B. (2022). Mental Health Supports by Jurisdictions. Continuing Medical Education hosted by the Canadian Scleroderma Research Group, Scleroderma Canada, and Scleroderma Society of Ontario. Niagara Falls, Ontario.September 16, 2022.  


Rice, D.B. (2022). Maintaining Healthy Relationships. Scleroderma Support Group London. September 11, 2022. 


Rice, D.B. The DEPRESsion Screening Data (DEPRESSD) Project: Using Individual Participant Data Meta-Analysis to Address Challenges in Evaluating Screening Tool Accuracy in Depression and Perinatal Mental Health. Mood Disorders Treatment and Research Clinic: Academic Rounds – St. Joseph’s Healthcare Hamilton. June 26, 2022. 


Rice, D.B., Thanh, C.Q., Hudson, M. Facing Post-COVID Frontiers for People Living with Scleroderma: What Do We Need to Know? Scleroderma Canada. April 12, 2022

bottom of page